These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter? Halperin DM; Varadhachary GR Curr Oncol Rep; 2014 Feb; 16(2):366. PubMed ID: 24445498 [TBL] [Abstract][Full Text] [Related]
53. Neoadjuvant Therapy for Pancreatic Cancer: Systematic Review of Postoperative Morbidity, Mortality, and Complications. Verma V; Li J; Lin C Am J Clin Oncol; 2016 Jun; 39(3):302-13. PubMed ID: 26950464 [TBL] [Abstract][Full Text] [Related]
54. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma. Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715 [TBL] [Abstract][Full Text] [Related]
55. [Hope and frustration of neoadjuvant chemotherapy for resectable pancreatic cancer]. Lu C; Miao Y; Gao WT Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):813-816. PubMed ID: 30392300 [TBL] [Abstract][Full Text] [Related]
56. Surgical Planning for "Borderline Resectable" and "Locally Advanced" Pancreatic Cancer During Open Pancreatic Resection. Tamburrino D; De Stefano F; Belfiori G; Partelli S; Crippa S; Falconi M J Gastrointest Surg; 2023 Dec; 27(12):3014-3023. PubMed ID: 37783912 [TBL] [Abstract][Full Text] [Related]
57. Pancreatic cancer: advances in treatment. Mohammed S; Van Buren G; Fisher WE World J Gastroenterol; 2014 Jul; 20(28):9354-60. PubMed ID: 25071330 [TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit? Ren L; Mota Reyes C; Friess H; Demir IE Langenbecks Arch Surg; 2020 Nov; 405(7):879-887. PubMed ID: 32776259 [TBL] [Abstract][Full Text] [Related]
59. A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. Laurence JM; Tran PD; Morarji K; Eslick GD; Lam VW; Sandroussi C J Gastrointest Surg; 2011 Nov; 15(11):2059-69. PubMed ID: 21913045 [TBL] [Abstract][Full Text] [Related]
60. Trends in the treatment of pancreatic cancer in Japan. Matsuki R; Arai T; Kogure M; Suzuki Y; Sakamoto Y Biosci Trends; 2021 Jul; 15(3):135-137. PubMed ID: 33776020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]